The Patient Advocate for PGx | PGX for Pharmacists

The Patient Advocate for PGx | PGX for Pharmacists

Pharmacy Podcast Network

According to the American Association for Cancer Research, 80-90% of the administered dose of the cancer medication 5-fluorouracil of 5FU is degraded by the enzyme dihydropyridine dehydrogenase or DPD for short.

(clinca

Related tracks

See all